title: Long term follow-up after a single intravitreal ranibizumab injection for choroidal neovascularisation secondary to optic nerve head drusen in a 5-year-old child.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Baillif
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Nguyen
authors.forename: Anne
authors.initials: A
authors.lastname: Colleville-El Hayek
authors.forename: Frédéric
authors.initials: F
authors.lastname: Bétis
mesh_terms: D000768:Anesthesia, General; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D015594:Optic Disk Drusen / Q000150:complications* / Q000175:diagnosis; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab